Compare Newmont Corporation (NEM) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs Sana Biotechnology Inc — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Newmont Corporation is far larger — about 109× Sana Biotechnology Inc's market cap, and Newmont Corporation pays a 1.17% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| NEM | SANA | |
|---|---|---|
Market Cap | $95.23B | $873.84M |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $5.92 |
52-Week Low | $59.86 | $2.68 |
Enterprise Value | $91.98B | $848.03M |
Dividend Yield | 1.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
